Using Inside-Out Open Innovation to Recover Abandoned Pharmaceutical Compounds
Pharmaceutical drug development costs have risen rapidly over the past twenty years. However, the number of new molecular entities being approved has not increased. As pharmaceutical companies scale back their R&D in light of this deteriorating productivity, significant unmet medical needs rem...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Universidade do Porto, Faculdade de Engenharia (FEUP)
2015-07-01
|
Series: | Journal of Innovation Management |
Subjects: | |
Online Access: | https://journalsojs3.fe.up.pt/index.php/jim/article/view/280 |